about
Magnetic Resonance Imaging of Glucose Uptake and Metabolism in Patients with Head and Neck CancerDevelopment of a software for quantitative evaluation radiotherapy target and organ-at-risk segmentation comparison.Estimation of daily interfractional larynx residual setup error after isocentric alignment for head and neck radiotherapy: quality assurance implications for target volume and organs-at-risk margination using daily CT on- rails imagingRadiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.Radiation Therapy is Independently Associated with Worse Survival After R0-Resection for Stage I-II Non-small Cell Lung Cancer: An Analysis of the National Cancer Data Base.Case report and summary of literature: giant perineal keloids treated with post-excisional radiotherapy.Method comparison of ultrasound and kilovoltage x-ray fiducial marker imaging for prostate radiotherapy targeting.Metabolic interrogation as a tool to optimize chemotherapeutic regimens.Beam path toxicity in candidate organs-at-risk: assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapy.Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous CarcinomaIntensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis.Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort.Standing on the shoulders of giants: results from the Radiation Oncology Academic Development and Mentorship Assessment Project (ROADMAP).Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck ModuleConditional survival and the choice of conditioning set for patients with colon cancer: an analysis of NSABP trials C-03 through C-07.Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting.Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer.Nomogram for predicting symptom severity during radiation therapy for head and neck cancer.Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008.Prospective randomized double-blind study of atlas-based organ-at-risk autosegmentation-assisted radiation planning in head and neck cancerConsequences of anorectal cancer atlas implementation in the cooperative group setting: radiobiologic analysis of a prospective randomized in silico target delineation study.Novel low-kVp beamlet system for choroidal melanomaIndividualized estimation of conditional survival for patients with head and neck cancer.Quality assurance assessment of diagnostic and radiation therapy-simulation CT image registration for head and neck radiation therapy: anatomic region of interest-based comparison of rigid and deformable algorithms.Gender differences in publication productivity, academic position, career duration, and funding among U.S. academic radiation oncology faculty.Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade surveyRetrospective study of the treatment of urethral cancer.Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer.Prospective observer and software-based assessment of magnetic resonance imaging quality in head and neck cancer: Should standard positioning and immobilization be required for radiation therapy applications?Comparison of measurement methods with a mixed effects procedure accounting for replicated evaluations (COM3PARE): method comparison algorithm implementation for head and neck IGRT positional verificationThymic carcinoma: state of the art review.Early prostate-specific antigen (PSA) kinetics following prostate carcinoma radiotherapy: prognostic value of a time-and-PSA threshold model.Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1-2 glottic cancerCharacteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: quantitative image analysis of post-radiotherapy response.Effect of brain stem and dorsal vagus complex dosimetry on nausea and vomiting in head and neck intensity-modulated radiation therapy.Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiformeThe MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development.CT-based volumetric tumor growth velocity: A novel imaging prognostic indicator in oropharyngeal cancer patients receiving radiotherapy.Time and PSA threshold model prognosticates long-term overall and disease-specific survival in prostate cancer patients as early as 3 months after external beam radiation therapy.Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx: preliminary results from a prospective pilot study.
P50
Q28828741-ED229DE6-7F23-47A4-9F55-E1D690A8BD4BQ30486369-B920EF92-5E17-467A-BF7A-0A1B4E376DBAQ30809590-C396BD8C-BEE9-4F58-91F3-97D9347D40EFQ31151565-05AC699D-7C91-4C30-898A-5F1BC97A281EQ31159181-F8E89CC7-C25C-4599-9F33-983E36B5EF75Q33240330-5DF42FEC-A32E-4C64-BD22-C57F2C875035Q33258096-83E21BE5-5D7F-40B9-B2FF-E4A1C2A84537Q33566853-5782E350-BDC6-4814-8831-3E26900D3AACQ33779881-FA2F9405-49C0-47FA-8328-578152F20762Q33809120-CC847FE6-7480-497D-8A99-CFC877A25E23Q33809126-BF3B0DB8-0AC1-4F51-A8D2-5E13A934AF1CQ33809135-15707663-AA16-49E3-98CB-A2DCC240AC70Q33859376-59E1D30B-4DEF-4F77-9DF5-A5EAD7CAE218Q33893165-21414571-9323-4BC6-AD16-FDFE5ACB9220Q33897641-87B3232E-9FBB-4C2A-A9D3-410D29811CF6Q34088596-572EF106-4378-4A60-A231-60E13F037F0BQ34232203-D27BD356-124E-44C5-A72D-7A8C5FED172BQ34287961-2BB3C33B-FB12-4E1F-8F43-5739EDF29C11Q34298754-5A3889BA-BE09-4F2E-9734-DD87D7A7E8DFQ34615769-C44173B4-62D0-4B50-BB47-046F3BB54000Q34643927-D09328AE-0086-468B-AFAF-BC9052D9BA97Q35062370-FACC5260-514F-4AFF-8A01-EC1FAACF2C7DQ35164894-12868DD5-12A1-4DFF-BE6D-F6403A055A4CQ35174711-E8601C8E-638D-4DCF-8D22-76422F900495Q35230892-AD274C28-A887-453C-B8AD-8E5332513FC4Q35582536-104A21C6-6D52-4003-B11B-0E74DD8E8DB9Q35603331-0DA69EF4-7089-4CBB-8794-55293DC1C0FEQ35609692-25BAD30A-6AD1-43A6-B563-BC18CE3E6F72Q35752309-1A753FD5-F2F4-4B97-A35A-2F6164386172Q35756671-5D4D8EDF-96F6-46A3-9335-31134F418B1FQ35796216-B9A3DA98-6FEF-4774-8C14-0B5D1B036D8AQ35819897-97F2AE0A-6DE9-4F01-B918-33F3169F1F7EQ35839993-632AA23B-1B35-4F3B-A418-C09E4A90EEBBQ35853734-6D2B1EC7-F270-4F39-BFD1-BA731237254AQ35876213-C3D37ECB-D25C-4AEF-85CF-31D72C3C376FQ35924621-0245BCB3-8099-445B-9D65-324D6C9B24ADQ36176801-1F1221D5-7710-4D2A-B574-6CB15608E791Q36219365-36F51DCA-BC60-473C-AB3E-999E09E4F4C0Q36255766-A52873D0-B47E-4891-929F-247A5C74F01FQ36470246-BDEB6BC4-CF59-4830-BFED-EC9102DAF732
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Clifton D. Fuller
@ast
Clifton D. Fuller
@en
Clifton D. Fuller
@es
Clifton D. Fuller
@sl
type
label
Clifton D. Fuller
@ast
Clifton D. Fuller
@en
Clifton D. Fuller
@es
Clifton D. Fuller
@sl
altLabel
Dave Fuller
@en
prefLabel
Clifton D. Fuller
@ast
Clifton D. Fuller
@en
Clifton D. Fuller
@es
Clifton D. Fuller
@sl
P106
P1153
7202433367
P21
P2456
P31
P496
0000-0002-5264-3994